School of Medicine


Showing 11-20 of 36 Results

  • Howard H Fenn MD

    Howard H Fenn MD

    Clinical Associate Professor (Affiliated) [Vapahcs], Psychiatry and Behavioral Sciences

    Bio CLINICAL:
    Inpatient psychiatry attending at VA HCS Palo Alto for over 30 years.
    Medical Director, Geriatric Psychiatry unit, VA HCSC Palo Alto/Menlo Park for 10 years
    Outpatient psychiatrist at Palo Alto Medical foundation/Sutter for 15 years


    LEGAL/FORENSIC:
    Consultation practice on legal issues and court testimony for >40 years
    Expert consultant/witness for Coleman vs. California Department of Corrections for 4 years
    Qualified Medical Examiner (QME) for Division of Worker's Compensation for 15 years
    Compensation and Pension Unit, VA HCS Palo Alto for 5 years

    SEMINAR LEADER:
    Psychiatric Issues in Cognitive Impairment -- Stanford/VA Alzheimer's Center (SVAAC)
    Legal Aspects of Geriatric Psychiatry (Stanford/VA Geriatric Psychiatry Fellowship
    Didactic topics on inpatient psychiatry rotation for Stanford Geriatric Psychiatry fellows

    EDUCATIONAL/ADMINISTRATIVE:
    Program Director, Stanford/VA Geriatric Psychiatry Fellowship, 3 years
    Site Director, Inpatient Psychiatry Rotation/Geriatric Medicine Fellowship --6 years

    SCHOLARSHIP:
    Lead Editor of textbook, Inpatient Geriatric Psychiatry, published by Springer in 2019.
    Slide presentations published by the American Society of Clinical Pharmacology (ASCP), editor Ira Glick, MD, entitled:
    --Pharmacological Treatment of PTSD
    --Behavioral and Psychological symptoms of Dementia
    Chapters, review articles on topics of Medication management for Major Neurocognitive Disorder with Behavioral Disturbance
    Chapter in Inpatient Geriatric Psychiatry, in On-Call Geriatric Psychiatry (2016), Springer.
    .

  • Lief Ericsson Fenno

    Lief Ericsson Fenno

    Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Fenno is a psychiatrist and Instructor at Stanford University School of Medicine.

    Leveraging his strengths in neuroscience research and bioengineering, his goal is to design, construct, validate, and apply novel molecular and viral tools to understand the brain in health and disease for the benefit of diverse patient populations. His clinical interests include the treatment of substance use disorders and co-occurring mood disorders.

    His specific research interests include the development and application of novel optogenetic tools that combine genetically encoded molecules and light to modulate neurons. Dr. Fenno directs a team focused on expanding the use of novel, intersectional viral targeting approaches, with the objective of precisely establishing links between neuron circuitry and behavior. He has patented advances for optically controlled CNS dysfunction and social dysfunction.

    Dr. Fenno has co-written articles on optogenetic tools and other topics in the journals Annual Review of Neuroscience, Neurobiology of Mental Illness, Molecular Psychiatry, Current Protocols in Neuroscience, Nature, and Cell. He is also the co-author of articles on neural mechanisms of autism spectrum disorder, which have appeared in Science Translational Medicine and Nature.

    Dr. Fenno has delivered presentations worldwide at events including the meeting of the National Science Foundation NeuroNex Program of Next Generation Networks for Neuroscience. He also has been an invited speaker at the Robarts Research Institute, a Canada-based facility accelerating medical discovery of treatments for some of the most debilitating diseases of our time, and the Gordon Research Conference on Molecular Pharmacology, an international forum for the presentation of pre-publication frontier research.

    For his scholarship and teaching achievements, Dr. Fenno has won numerous honors. They include the Laughlin Fellowship from the American College of Psychiatrists, which honors individuals deemed likely to make a significant contribution to the field of psychiatry, and the Humanism and Excellence in Teaching Award from the Arnold P. Gold Foundation, which honors exceptional teaching skills and commitment to the compassionate treatment of patients and families, students, and colleagues.

    Dr. Fenno is a member of the Society for Neuroscience, The American Medical Association, and the American Society of Addiction Medicine.

Latest information on COVID-19